PHEOCHROMOCYTOMA/PARAGANGLIOMA
Clinical trials for PHEOCHROMOCYTOMA/PARAGANGLIOMA explained in plain language.
Never miss a new study
Get alerted when new PHEOCHROMOCYTOMA/PARAGANGLIOMA trials appear
Sign up with your email to follow new studies for PHEOCHROMOCYTOMA/PARAGANGLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug study aims to control rare genetic tumor disorder
Disease control Recruiting nowThis study is testing how well the drug belzutifan works for controlling tumors in people with von Hippel-Lindau (VHL) syndrome, a rare genetic condition that causes tumors in multiple organs. Researchers will follow 100 patients in Brazil to see how effectively the drug shrinks …
Matched conditions: PHEOCHROMOCYTOMA/PARAGANGLIOMA
Phase: PHASE2 • Sponsor: José Claudio Casali da Rocha • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New pill targets multiple rare cancers in major trial
Disease control Recruiting nowThis study is testing an oral medication called belzutifan for people with advanced rare tumors, including pheochromocytoma, pancreatic neuroendocrine tumors, VHL disease-associated tumors, and certain gastrointestinal cancers. The main goal is to see how well the drug shrinks tu…
Matched conditions: PHEOCHROMOCYTOMA/PARAGANGLIOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Scientists hunt for hidden genetic causes of childhood cancers in families
Knowledge-focused Recruiting nowThis study aims to discover new genes that cause cancer to run in families, especially those affecting children. Researchers will collect health information, blood, and sometimes leftover tumor samples from families where multiple members have had cancer. The goal is to build a l…
Matched conditions: PHEOCHROMOCYTOMA/PARAGANGLIOMA
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC